TY - JOUR
T1 - Nanoscale Diamond-Based Formulation as an Immunomodulator and Potential Therapeutic for Lymphoma
AU - Paladhi, Ankush
AU - Rej, Abhinandan
AU - Sarkar, Debanjan
AU - Singh, Ranjeet
AU - Bhattacharyya, Sankar
AU - Sarkar, Prasanta Kumar
AU - Kar, Pulak Kanti
AU - Manna, Partha Pratim
AU - Hira, Sumit Kumar
N1 - Publisher Copyright:
Copyright © 2022 Paladhi, Rej, Sarkar, Singh, Bhattacharyya, Sarkar, Kar, Manna and Hira.
PY - 2022/4/4
Y1 - 2022/4/4
N2 - Integrative medicine practices, such as Ayurveda, are popular in India and many South Asian countries, yet basic research to investigate the concepts, procedures, and medical benefits of ayurvedic products has received little attention and is not fully understood. Here, we report a functional nanodiamond-based traditional Ayurvedic herbomineral formulation, Heerak Bhasma (Ayu_ND), for the treatment of solid tumors called Dalton’s lymphoma generated in CD1 mice. Ayu_ND-mediated immunostimulation significantly reduces tumor cell proliferation and induces apoptosis aided by the active participation of dendritic cells. Immunomodulatory Ayu_ND treatment is highly immunostimulatory and drives dendritic cells to produce TNF-α. Treatment with Ayu_ND significantly reduces the tumor volume, inhibits metastasis in distant vascularized organs, and increases the life span of tumor-bearing animals compared with untreated littermates. These events were associated with elevated serum levels of the protective cytokines IFN-γ and TNF-α and downregulated the disease, exacerbating TGF-β. Ayu_ND-mediated therapeutic success was also accompanied by the depletion of regulatory T cells and enhanced vaccine-induced T-cell immunity, guided by the restoration of the memory CD8+ T-cell pool and prevention of PD-1-mediated T cell exhaustion. The results provide a basis for further evaluation of ayurvedic formulations and drug efficacy in treating cancers.
AB - Integrative medicine practices, such as Ayurveda, are popular in India and many South Asian countries, yet basic research to investigate the concepts, procedures, and medical benefits of ayurvedic products has received little attention and is not fully understood. Here, we report a functional nanodiamond-based traditional Ayurvedic herbomineral formulation, Heerak Bhasma (Ayu_ND), for the treatment of solid tumors called Dalton’s lymphoma generated in CD1 mice. Ayu_ND-mediated immunostimulation significantly reduces tumor cell proliferation and induces apoptosis aided by the active participation of dendritic cells. Immunomodulatory Ayu_ND treatment is highly immunostimulatory and drives dendritic cells to produce TNF-α. Treatment with Ayu_ND significantly reduces the tumor volume, inhibits metastasis in distant vascularized organs, and increases the life span of tumor-bearing animals compared with untreated littermates. These events were associated with elevated serum levels of the protective cytokines IFN-γ and TNF-α and downregulated the disease, exacerbating TGF-β. Ayu_ND-mediated therapeutic success was also accompanied by the depletion of regulatory T cells and enhanced vaccine-induced T-cell immunity, guided by the restoration of the memory CD8+ T-cell pool and prevention of PD-1-mediated T cell exhaustion. The results provide a basis for further evaluation of ayurvedic formulations and drug efficacy in treating cancers.
KW - ayurveda
KW - dendritic cell
KW - Heerak Bhasma
KW - lymphoma
KW - nanodiamond
KW - T cell
UR - http://www.scopus.com/inward/record.url?scp=85128558914&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85128558914&partnerID=8YFLogxK
U2 - 10.3389/fphar.2022.852065
DO - 10.3389/fphar.2022.852065
M3 - Article
AN - SCOPUS:85128558914
SN - 1663-9812
VL - 13
JO - Frontiers in Pharmacology
JF - Frontiers in Pharmacology
M1 - 852065
ER -